Filter
1600
Text search:
drug
financing
Featured
104
557
Language
Document type
1068
242
107
89
39
34
10
7
3
1
Countries
71
66
54
48
47
46
46
45
38
37
37
37
34
30
29
28
27
27
27
26
24
21
20
18
17
16
15
14
13
12
11
11
10
8
7
7
7
7
7
7
6
5
5
5
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
771
97
70
42
25
10
7
Toolboxes
207
194
83
68
48
42
33
29
26
25
25
20
19
15
13
12
10
10
4
2
2
1
1
Meeting Report
27–30 June 2017 Manila, Philippines
UNAIDS 2016, Reference
HIV care and support taking into account the 2016 WHO consolidated guidelines
Global Fund Investment Guidance for Eastern Europe and Central Asia
Accessed: 29.09.2019
Глобальная статистика свидетельствует о том, что бремя туберкулеза более актуально в городских регионах. Тем не менее, в тех странах, где большая часть населения п
...
A case study from Bosnia and Herzegovina Eurasian Harm Reduction Network
The case study was prepared by Samir Ibisevic, President of PROI between March and June 2016 and edited by Graham Shaw.
EHRN is grateful to all who contributed to this document, especially: Dr. Serifa Godinjak, Chairperson
...
Accessed: 26.09.2019
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0169530 February 16, 2017
Evaluation report
December 2014
Информационный бюллетень содержит краткое изложение новой стратегии Глобального фонда, опыта, накопленного в ходе первого цикла финансирования на основе выделен
...
Zero new HIV infections
Zero Discrimination
Zero AIDS related deaths
Accessed: 04.10.2019
Global Tuberculosis Report 2021
recommended
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The
...
Kyiv, Ukraine 22-24 November 2010
Meeting Report
Putting Asia’s HIV response back on track
UNAIDS 2018 / Guidance
Guidance for policy-makers, and people living with, at risk of or affected by HIV
